Health Innovation
Recent stories about health innovation
48Hour Discovery awarded $800,000 to accelerate drug development
University of Alberta biotechnology spin-off company 48Hour Discovery has been granted $800,000 to initiate peptide-based drug discovery using its patented drug discovery platform.
Read the story
Made-in-Edmonton cancer drug receives Health Canada approval for Phase 1 human clinical trials
Edmonton-based oncology company Pacylex Pharmaceuticals has received Health Canada's approval to begin a Phase 1 clinical trial for its anti-cancer drug PCLX-001.
Read the story
U of A health research to receive $6.5M in federal funding
University of Alberta health research is getting a funding boost from the federal government through the Canadian Foundation for Innovation (CFI) to advance two projects: one that aims to better understand chronic health conditions and develop potential treatments, and another that investigates the impact of toxins on people’s health.
Read the story
Hepion Pharmaceuticals raises US$88.4M to accelerate drug development
Hepion Pharmaceuticals has announced the closing of the company's latest public offering, which raised gross proceeds of US$88.4 million in less than a week.
Read the story
Tevosol merges with global biotechnology company to launch 'groundbreaking' transplant solutions
Edmonton-based medical device startup, Tevosol, is expanding its global footprint after it struck a deal to merge with Bridge to Life, a leading global supplier of organ preservation solutions.
Read the story
Edmonton-made nanotechnology aims to boost Alberta's COVID-19 testing capacity
Applied Quantum Materials (AQM) is using magnetic nanoparticles to help bolster Alberta's COVID-19 testing program. It has secured a deal with Alberta Health Services to provide the provincial laboratory system with COVID-19 testing kits.
Read the story
'Huge potential opportunity' for Edmonton pharmaceutical industry as FDA approves Aurinia lupus drug
A made-in-Edmonton drug that can treat lupus nephritis received the first U.S. Food and Drug Administration (FDA) approval as an oral therapy for the disease, Victoria-based Aurinia Pharmaceuticals announced in a statement on Jan. 22.
Read the story
Digital Health Summit focuses on virtual care, calls for industry cooperation for long-term sustainability
The surge of digital technologies during the COVID-19 pandemic brought together more than 2,000 world-class leaders, entrepreneurs, and innovators at Alberta's Digital Health Summit on Jan. 26. The virtual event was part of Inventures Unbound and Alberta Innovates Digital Health Strategy.
Read the story
Alberta cancer patient undergoes first legal psychedelic-assisted therapy in the province
An Alberta patient with Stage 4 cancer is the first in the province to undergo legal psychedelic-assisted therapy. Tony White has been struggling with anxiety and depression due to his terminal illness. He said legal psychedelic therapy has helped him "relieve end-of-life distress."
Read the story